WO2005083445A3 - Methods for determining the effects of products on epithelial tissue - Google Patents

Methods for determining the effects of products on epithelial tissue Download PDF

Info

Publication number
WO2005083445A3
WO2005083445A3 PCT/US2005/006335 US2005006335W WO2005083445A3 WO 2005083445 A3 WO2005083445 A3 WO 2005083445A3 US 2005006335 W US2005006335 W US 2005006335W WO 2005083445 A3 WO2005083445 A3 WO 2005083445A3
Authority
WO
WIPO (PCT)
Prior art keywords
epithelial tissue
products
determining
effects
methods
Prior art date
Application number
PCT/US2005/006335
Other languages
French (fr)
Other versions
WO2005083445A2 (en
Inventor
Stephen Worth Hendrix
Scott Edward Osborne
Susan Baldwin
Original Assignee
Procter & Gamble
Stephen Worth Hendrix
Scott Edward Osborne
Susan Baldwin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble, Stephen Worth Hendrix, Scott Edward Osborne, Susan Baldwin filed Critical Procter & Gamble
Priority to EP05723982A priority Critical patent/EP1718978A2/en
Publication of WO2005083445A2 publication Critical patent/WO2005083445A2/en
Publication of WO2005083445A3 publication Critical patent/WO2005083445A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin

Abstract

A method for determining the relative benefits of products which affect animal epithelial tissue is provided. Also provided is a method for evaluating quantitative changes on one or more affected surfaces of epithelial tissue of a subject caused by a test product.
PCT/US2005/006335 2004-02-26 2005-02-25 Methods for determining the effects of products on epithelial tissue WO2005083445A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05723982A EP1718978A2 (en) 2004-02-26 2005-02-25 Methods for determining the effects of products on epithelial tissue

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/787,560 US7229778B2 (en) 2004-02-26 2004-02-26 Methods for determining the relative benefits and/or evaluating quantitative changes of products on epithelial tissue
US10/787,560 2004-02-26

Publications (2)

Publication Number Publication Date
WO2005083445A2 WO2005083445A2 (en) 2005-09-09
WO2005083445A3 true WO2005083445A3 (en) 2005-11-24

Family

ID=34886803

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/006335 WO2005083445A2 (en) 2004-02-26 2005-02-25 Methods for determining the effects of products on epithelial tissue

Country Status (3)

Country Link
US (5) US7229778B2 (en)
EP (1) EP1718978A2 (en)
WO (1) WO2005083445A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229778B2 (en) * 2004-02-26 2007-06-12 The Procter & Gamble Company Methods for determining the relative benefits and/or evaluating quantitative changes of products on epithelial tissue
FR2925312B1 (en) * 2007-12-19 2016-12-02 Oreal COSMETIC USE OF DESMOGLEINE I PROTEINS
FR2932087B1 (en) * 2008-06-10 2012-10-12 Oreal COSMETIC USE OF DESMOPLAKINE-LIKE PROTEINS FOR THE TREATMENT OF SKIN DROUGHT
WO2010102301A1 (en) * 2009-03-06 2010-09-10 Jennifer Hollenstein Method and apparatus for suspending magnetic microparticles
EP2524225B1 (en) 2010-01-17 2017-04-19 The Procter and Gamble Company Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
CA2800537C (en) 2010-06-11 2016-02-09 The Procter & Gamble Company Compositions for treating skin
US9671410B2 (en) 2011-01-16 2017-06-06 The Procter & Gamble Company Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
US8383167B2 (en) 2011-03-08 2013-02-26 Elc Management, Llc Method for cosmetically treating caspase-14 deficiency
US9375447B2 (en) * 2013-03-14 2016-06-28 National Cheng Kung University Modified hyaluronan and uses thereof in cancer treatment
FR3004810B1 (en) 2013-04-19 2016-04-08 Expanscience Lab USE OF BARRIER BIOMARKERS FOR EVALUATION OF THE EFFECTIVENESS OF ASSETS.
FR3019186B1 (en) * 2014-03-31 2019-06-07 Laboratoires Expanscience METHODS OF EVALUATING THE DELETE EFFECTS OF URINE ON CHILDREN'S SKIN
MX2017006148A (en) 2014-11-10 2017-07-27 Procter & Gamble Personal care compositions with two benefit phases.
WO2016077327A1 (en) 2014-11-10 2016-05-19 The Procter & Gamble Company Personal care compositions with two benefit phases
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
EP3217950B1 (en) 2014-11-10 2020-01-29 The Procter and Gamble Company Personal care compositions
HUE056062T2 (en) 2016-02-05 2022-01-28 Hoffmann La Roche Medical device for detecting at least one analyte in a body fluid
EP3202324B1 (en) 2016-02-05 2021-11-17 Roche Diabetes Care GmbH Medical device for detecting at least one analyte in a body fluid
MA44017A (en) * 2016-02-09 2018-12-19 Ecolab Usa Inc METHOD AND COMPOSITION FOR RAPID DETECTION OF PROTEIN SOIL
WO2019079405A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company Aerosol foam skin cleanser
WO2019079409A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company Aerosol foam skin cleanser
WO2019113035A1 (en) 2017-12-08 2019-06-13 The Procter & Gamble Company Methods of screening for mild skin cleanser
ES2905955T3 (en) 2017-12-21 2022-04-12 Hoffmann La Roche Medical system and manufacturing procedure thereof
MX2020006887A (en) * 2018-01-03 2020-09-07 Unilever Ip Holdings B V Method for demonstrating cleansing efficacy.
EP3775885A1 (en) * 2018-05-17 2021-02-17 Unilever N.V. Evaluating the efficacy of leave-on cosmetic compositions to protect from pollutants
CN113015904A (en) 2018-11-29 2021-06-22 宝洁公司 Method for screening personal care products
JP7345340B2 (en) 2019-02-28 2023-09-15 小林製薬株式会社 How to measure ceramide in stratum corneum

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002002A1 (en) * 1994-07-08 1996-01-25 Schalken Jack A Assay for increased invasiveness of epithelial cells
US20030170739A1 (en) * 2001-11-08 2003-09-11 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Gene expression for analyzing photodamage
EP1388734A1 (en) * 2002-08-01 2004-02-11 MTM Laboratories AG Method for solution based diagnosis
EP1394274A2 (en) * 2002-08-06 2004-03-03 Genox Research, Inc. Methods of testing for bronchial asthma or chronic obstructive pulmonary disease
EP1426381A1 (en) * 1995-10-02 2004-06-09 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES An epithelial protein and DNA thereof for use in early cancer detection

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN214095A0 (en) * 1995-04-03 1995-04-27 Australian Water Technologies Pty Ltd Method for detecting microorganisms using flow cytometry
US5675517A (en) * 1995-04-25 1997-10-07 Systemix Fluorescence spectral overlap compensation for high speed flow cytometry systems
AU7398996A (en) * 1995-10-11 1997-04-30 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US5736330A (en) * 1995-10-11 1998-04-07 Luminex Corporation Method and compositions for flow cytometric determination of DNA sequences
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US6449562B1 (en) * 1996-10-10 2002-09-10 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US6139800A (en) * 1997-06-23 2000-10-31 Luminex Corporation Interlaced lasers for multiple fluorescence measurement
KR20010031140A (en) * 1997-10-14 2001-04-16 루미넥스 코포레이션 Precision fluorescently dyed particles and methods of making and using same
CA2260991C (en) * 1997-11-18 2009-03-24 Bio-Rad Laboratories, Inc. Multiplex flow immunoassays with magnetic particles as solid phase
DE69907630T2 (en) * 1998-01-22 2004-02-26 Luminex Corp., Austin MICROPARTICLES WITH MULTIPLE FLUORESCENCE SIGNALS
US6248590B1 (en) * 1998-02-27 2001-06-19 Cytomation, Inc. Method and apparatus for flow cytometry
WO1999058955A1 (en) * 1998-05-14 1999-11-18 Luminex Corporation Multi-analyte diagnostic system and computer implemented process for same
JP3946444B2 (en) * 1998-05-14 2007-07-18 ルミネックス コーポレイション Configuration and method for zero dead time of flow cytometer
AU3996299A (en) * 1998-05-14 1999-11-29 Luminex Corporation Diode laser based measurement apparatus
US6696304B1 (en) * 1999-02-24 2004-02-24 Luminex Corporation Particulate solid phase immobilized protein quantitation
AU6779200A (en) * 1999-08-17 2001-03-13 Luminex Corporation Encapsulation of fluorescent particles
AU6779700A (en) * 1999-08-17 2001-03-13 Luminex Corporation Microparticles with multiple fluorescent signals and methods of using same
US6549275B1 (en) * 2000-08-02 2003-04-15 Honeywell International Inc. Optical detection system for flow cytometry
US6382228B1 (en) * 2000-08-02 2002-05-07 Honeywell International Inc. Fluid driving system for flow cytometry
US20020182609A1 (en) * 2000-08-16 2002-12-05 Luminex Corporation Microsphere based oligonucleotide ligation assays, kits, and methods of use, including high-throughput genotyping
JP2004537712A (en) * 2000-10-18 2004-12-16 バーチャル・アレイズ・インコーポレーテッド Multiple cell analysis system
US6828109B2 (en) * 2000-12-15 2004-12-07 James R. Bell, Jr. Methods for detecting an analyte of interest using catalyzed reporter deposition of tyramide
US7229778B2 (en) * 2004-02-26 2007-06-12 The Procter & Gamble Company Methods for determining the relative benefits and/or evaluating quantitative changes of products on epithelial tissue

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002002A1 (en) * 1994-07-08 1996-01-25 Schalken Jack A Assay for increased invasiveness of epithelial cells
EP1426381A1 (en) * 1995-10-02 2004-06-09 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES An epithelial protein and DNA thereof for use in early cancer detection
US20030170739A1 (en) * 2001-11-08 2003-09-11 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Gene expression for analyzing photodamage
EP1388734A1 (en) * 2002-08-01 2004-02-11 MTM Laboratories AG Method for solution based diagnosis
EP1394274A2 (en) * 2002-08-06 2004-03-03 Genox Research, Inc. Methods of testing for bronchial asthma or chronic obstructive pulmonary disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BALDWIN S ET AL: "Skin benefits from continuous topical administration of a zinc oxide/petrolatum formulation by a novel disposable diaper", JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2001 UNITED KINGDOM, vol. 15, no. SUPPL. 1, 2001, pages 5 - 11, XP008048309, ISSN: 0926-9959 *
FARAGE-ELAWAR M A ET AL: "A clinical method for testing the safety of catamenial pads", GYNECOLOGIC AND OBSTETRIC INVESTIGATION, vol. 44, no. 4, November 1997 (1997-11-01), pages 260 - 264, XP008048307, ISSN: 0378-7346 *
ODIO MAURICIO R ET AL: "Continuous topical administration of a petrolatum formulation by a novel disposable diaper: 1. Effect on skin surface microtopography", DERMATOLOGY (BASEL), vol. 200, no. 3, 2000, pages 232 - 237, XP008048326, ISSN: 1018-8665 *

Also Published As

Publication number Publication date
US7229778B2 (en) 2007-06-12
US20070202490A1 (en) 2007-08-30
US7767389B2 (en) 2010-08-03
WO2005083445A2 (en) 2005-09-09
EP1718978A2 (en) 2006-11-08
US20070202488A1 (en) 2007-08-30
US20070202489A1 (en) 2007-08-30
US20070202491A1 (en) 2007-08-30
US7771924B2 (en) 2010-08-10
US7763419B2 (en) 2010-07-27
US20050191709A1 (en) 2005-09-01
US7771925B2 (en) 2010-08-10

Similar Documents

Publication Publication Date Title
WO2005083445A3 (en) Methods for determining the effects of products on epithelial tissue
WO2007059088A3 (en) Interferometer and method for measuring characteristics of optically unresolved surface features
EP2362226B8 (en) Diagnostic method for neurodegenerative diseases based on measurement of SIRT1 levels or activity
WO2009087359A3 (en) Internet activity evaluation method and system
EP1836473A4 (en) Evaluating method of the residual stress determining method using the continuous indentation method
WO2008042760A3 (en) Method and system for dynamically updating calibration parameters for an analyte sensor
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
WO2007087560A3 (en) Stroke inducing and monitoring system and method for using the same
WO2008018790A3 (en) Quality control of agricultural products based on gene expression
WO2005118516A3 (en) Method and apparatus for determining health condition
WO2008029277A3 (en) Detecting signal interference in a vehicle system
WO2008058014A3 (en) Method and apparatus for noninvasive probe/skin tissue contact sensing
EP1895804A4 (en) A method and a device for determining the measurement time of the inter-frequency measurement and an inter-frequency measurement method
WO2006107611A3 (en) Detection of an immune response to gdf-8 modulating agents
EP1955076A4 (en) Method for determining the quality of a biological sample
WO2004057336A3 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
WO2008155891A1 (en) Novel marker for arteriosclerotic disease
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
EP1865067A4 (en) Method for study, determination or evaluation
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
WO2006025850A3 (en) Method of detecting coliform bacteria from reflected light
WO2005012901A3 (en) Method for measuring aromatase activity
ECSP088146A (en) METHODS TO DETERMINE THE PHARMACOCINETICS OF DIRECTED THERAPIES
AU2003236107A1 (en) Method of measuring accurate parallelism

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005723982

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005723982

Country of ref document: EP